Fracture risk following intermission of osteoporosis therapy.
Dennison, E M
Fracture risk following intermission of osteoporosis therapy. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Sep 2019 - 1733-1743 p. digital
Publication Type: Journal Article; Systematic Review
1433-2965
10.1007/s00198-019-05002-w doi
Age Factors
Bisphosphonate-Associated Osteonecrosis of the Jaw--epidemiology
Bone Density--physiology
Bone Density Conservation Agents--administration & dosage
Clinical Decision-Making--methods
Denosumab--administration & dosage
Diphosphonates--administration & dosage
Drug Administration Schedule
Humans
Osteoporosis, Postmenopausal--drug therapy
Osteoporotic Fractures--epidemiology
Risk Assessment--methods
Risk Factors
Withholding Treatment
Fracture risk following intermission of osteoporosis therapy. [electronic resource] - Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Sep 2019 - 1733-1743 p. digital
Publication Type: Journal Article; Systematic Review
1433-2965
10.1007/s00198-019-05002-w doi
Age Factors
Bisphosphonate-Associated Osteonecrosis of the Jaw--epidemiology
Bone Density--physiology
Bone Density Conservation Agents--administration & dosage
Clinical Decision-Making--methods
Denosumab--administration & dosage
Diphosphonates--administration & dosage
Drug Administration Schedule
Humans
Osteoporosis, Postmenopausal--drug therapy
Osteoporotic Fractures--epidemiology
Risk Assessment--methods
Risk Factors
Withholding Treatment